This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
DSM-Firmenich Gelecekteki Büyüme
Future kriter kontrolleri 4/6
DSM-Firmenich is forecasted to grow earnings and revenue by 20.5% and 11.1% per annum respectively. EPS is expected to grow by 18.3%. Return on equity is forecast to be 6.1% in 3 years.
Anahtar bilgiler
20.5%
Kazanç büyüme oranı
18.3%
EPS büyüme oranı
Chemicals kazanç büyümesi | 22.9% |
Gelir büyüme oranı | 11.1% |
Gelecekteki özkaynak getirisi | 6.1% |
Analist kapsamı | Good |
Son güncelleme | 31 May 2023 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Analyst Forecasts For Koninklijke DSM N.V. (AMS:DSM) Are Surging Higher
May 04Koninklijke DSM (AMS:DSM) Is Reinvesting At Lower Rates Of Return
Mar 27Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 09Here's Why We Think Koninklijke DSM (AMS:DSM) Is Well Worth Watching
Dec 06Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Nov 18Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)
Oct 31Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching
Sep 19Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?
Aug 23Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Aug 08Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)
Jul 23Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 30Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 16Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's
Apr 02Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70
Mar 19Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly
Feb 19Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?
Nov 23We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt
Oct 01Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?
Aug 24Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet
Jun 29Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price
May 24Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 29Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?
Mar 15Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 01Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment
Feb 16Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares
Feb 04Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2025 | 14,665 | 1,014 | 749 | 1,987 | 8 |
12/31/2024 | 13,934 | 685 | 847 | 1,966 | 9 |
12/31/2023 | 12,024 | 544 | 344 | 1,311 | 9 |
12/31/2022 | 8,390 | 454 | 314 | 965 | N/A |
9/30/2022 | 9,582 | 837 | 412 | 1,056 | N/A |
6/30/2022 | 9,802 | 1,082 | 510 | 1,147 | N/A |
3/31/2022 | 9,503 | 1,081 | 680 | 1,287 | N/A |
12/31/2021 | 7,269 | 820 | 850 | 1,427 | N/A |
9/30/2021 | 7,955 | 660 | 884 | 1,507 | N/A |
6/30/2021 | 7,558 | 493 | 906 | 1,489 | N/A |
3/31/2021 | 7,572 | 423 | 906 | 1,497 | N/A |
12/31/2020 | 8,106 | 448 | 868 | 1,494 | N/A |
9/30/2020 | 7,960 | 510 | 809 | 1,434 | N/A |
6/30/2020 | 8,034 | 557 | 810 | 1,462 | N/A |
3/31/2020 | 9,011 | 722 | 826 | 1,471 | N/A |
12/31/2019 | 7,998 | 675 | 744 | 1,385 | N/A |
9/30/2019 | 8,272 | 820 | 766 | 1,399 | N/A |
6/30/2019 | 8,502 | 794 | 747 | 1,395 | N/A |
3/31/2019 | 9,124 | 934 | 612 | 1,282 | N/A |
12/31/2018 | 9,267 | 1,069 | 698 | 1,391 | N/A |
9/30/2018 | 9,235 | 984 | 657 | 1,310 | N/A |
6/30/2018 | 9,106 | 2,082 | 550 | 1,170 | N/A |
3/31/2018 | 8,908 | 1,942 | 512 | 1,110 | N/A |
12/31/2017 | 8,632 | 1,761 | 441 | 996 | N/A |
9/30/2017 | 8,471 | 1,676 | 431 | 993 | N/A |
6/30/2017 | 8,333 | 738 | 470 | 1,028 | N/A |
3/31/2017 | 8,166 | 711 | 554 | 1,077 | N/A |
12/31/2016 | 7,920 | 645 | 523 | 1,018 | N/A |
9/30/2016 | 7,831 | 588 | N/A | 958 | N/A |
6/30/2016 | 7,778 | 274 | N/A | 914 | N/A |
3/31/2016 | 7,749 | 214 | N/A | 811 | N/A |
12/31/2015 | 7,722 | 174 | N/A | 696 | N/A |
9/30/2015 | 7,607 | 66 | N/A | 800 | N/A |
6/30/2015 | 7,456 | 114 | N/A | 820 | N/A |
3/31/2015 | 7,245 | 115 | N/A | 867 | N/A |
12/31/2014 | 7,051 | 123 | N/A | 808 | N/A |
9/30/2014 | 7,415 | 112 | N/A | 866 | N/A |
6/30/2014 | 7,834 | 138 | N/A | 885 | N/A |
3/31/2014 | 8,362 | 182 | N/A | 1,010 | N/A |
12/31/2013 | 8,858 | 252 | N/A | 998 | N/A |
9/30/2013 | 8,409 | 363 | N/A | 705 | N/A |
6/30/2013 | 8,500 | 335 | N/A | 638 | N/A |
3/31/2013 | 8,486 | 257 | N/A | 584 | N/A |
12/31/2012 | 8,588 | 280 | N/A | 730 | N/A |
9/30/2012 | 9,089 | 453 | N/A | 950 | N/A |
6/30/2012 | 9,107 | 543 | N/A | 1,020 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: DSM's forecast earnings growth (20.5% per year) is above the savings rate (0.4%).
Kazançlar ve Piyasa: DSM's earnings (20.5% per year) are forecast to grow faster than the Dutch market (16.1% per year).
Yüksek Büyüme Kazançları: DSM's earnings are expected to grow significantly over the next 3 years.
Gelir ve Pazar: DSM's revenue (11.1% per year) is forecast to grow faster than the Dutch market (3.9% per year).
Yüksek Büyüme Geliri: DSM's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: DSM's Return on Equity is forecast to be low in 3 years time (6.1%).